Incubation of Lymphocytes with IL-2 Causes the Appearance of Antitumor T Cells Carrying FC, CD25, and LFA-1 on the Surface

To carry out antitumor activity against cells that have lost surface antigens, human lymphocytes must have a certain repertoire of surface proteins capable of contacting a tumor cell and inducing programmed cell death in it. In this work, we showed that activation of healthy donor cells by IL-2 cyto...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Doklady. Biochemistry and biophysics 2023-02, Vol.508 (1), p.12-16
Hauptverfasser: Ivanova, O. K., Sharapova, T. N., Romanova, E. A., Yashin, D. V., Sashchenko, L. P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 16
container_issue 1
container_start_page 12
container_title Doklady. Biochemistry and biophysics
container_volume 508
creator Ivanova, O. K.
Sharapova, T. N.
Romanova, E. A.
Yashin, D. V.
Sashchenko, L. P.
description To carry out antitumor activity against cells that have lost surface antigens, human lymphocytes must have a certain repertoire of surface proteins capable of contacting a tumor cell and inducing programmed cell death in it. In this work, we showed that activation of healthy donor cells by IL-2 cytokine within 6 days causes the appearance of FasL, CD25, and LFA-1 proteins on CD8+CD25+ T lymphocytes, and also converts the LFA-1 protein into an active form having a high affinity for its target, ICAM-1 integrin. The appearance of these proteins on the surface of this subpopulation of lymphocytes allows them to induce programmed cell death in HLA-negative tumor cells.
doi_str_mv 10.1134/S160767292270003X
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10042969</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2791649069</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-359233954bfcc22105d345d3c2110f76ba1d3b32824e81797d913baaa0f7f1593</originalsourceid><addsrcrecordid>eNp1kU1v1DAQhiMEoqXwA7ggS1w4NOAZ58sntApdWCkShxaJm-U4zm6qjR1sp2j59XW6pXyJg2Vr3mfe8ehNkpdA3wKw7N0lFLQsSuSIJaWUfX2UnMZSlTLK4fHdu0wX_SR55v01pUiR5U-TE1YUOcsrPE1-bIyaWxkGa4jtSXMYp51Vh6A9-T6EHdk0KZJazj4Wwk6T1TRp6aRResFXJgxhHq0jV6TW-72PqHOHwWzJuj4n9QfMz4k0HWnWqxRInLF4XM6ul0o_T570cu_1i_v7LPmyvriqP6XN54-betWkKkMWUpZzZIznWdsrhQg071gWj0IA2pdFK6FjLcMKM11BycuOA2ullFHsIefsLHl_9J3mdtSd0iY4uReTG0bpDsLKQfypmGEntvZGAKUZ8mJxeHPv4Oy3WfsgxsGruK802s5eYAwBigoBI_r6L_Tazs7E_SLFocg4vTOEI6Wc9d7p_uE3QMUSrfgn2tjz6vc1Hjp-ZhkBPAI-Smar3a_R_3e9BZvoqv0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2791649069</pqid></control><display><type>article</type><title>Incubation of Lymphocytes with IL-2 Causes the Appearance of Antitumor T Cells Carrying FC, CD25, and LFA-1 on the Surface</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Ivanova, O. K. ; Sharapova, T. N. ; Romanova, E. A. ; Yashin, D. V. ; Sashchenko, L. P.</creator><creatorcontrib>Ivanova, O. K. ; Sharapova, T. N. ; Romanova, E. A. ; Yashin, D. V. ; Sashchenko, L. P.</creatorcontrib><description>To carry out antitumor activity against cells that have lost surface antigens, human lymphocytes must have a certain repertoire of surface proteins capable of contacting a tumor cell and inducing programmed cell death in it. In this work, we showed that activation of healthy donor cells by IL-2 cytokine within 6 days causes the appearance of FasL, CD25, and LFA-1 proteins on CD8+CD25+ T lymphocytes, and also converts the LFA-1 protein into an active form having a high affinity for its target, ICAM-1 integrin. The appearance of these proteins on the surface of this subpopulation of lymphocytes allows them to induce programmed cell death in HLA-negative tumor cells.</description><identifier>ISSN: 1607-6729</identifier><identifier>EISSN: 1608-3091</identifier><identifier>DOI: 10.1134/S160767292270003X</identifier><identifier>PMID: 36653582</identifier><language>eng</language><publisher>Moscow: Pleiades Publishing</publisher><subject>Antigens ; Antitumor activity ; Apoptosis ; Biochemistry ; Biochemistry, Biophysics, and Molecular Biology ; Biological and Medical Physics ; Biomedical and Life Sciences ; Biophysics ; CD25 antigen ; CD8 antigen ; CD8-Positive T-Lymphocytes ; Cell activation ; Cell death ; Cytokines ; FasL protein ; Humans ; Intercellular adhesion molecule 1 ; Interleukin 2 ; Interleukin-2 - metabolism ; LFA-1 antigen ; Life Sciences ; Lymphocyte Function-Associated Antigen-1 - metabolism ; Lymphocytes T ; Molecular Biology ; Surface antigens ; T-Lymphocytes - immunology ; Tumor cells</subject><ispartof>Doklady. Biochemistry and biophysics, 2023-02, Vol.508 (1), p.12-16</ispartof><rights>The Author(s) 2023. ISSN 1607-6729, Doklady Biochemistry and Biophysics, 2023, Vol. 508, pp. 12–16. © The Author(s), 2023. This article is an open access publication. ISSN 1607-6729, Doklady Biochemistry and Biophysics, 2022. © The Author(s), 2022. This article is an open access publication.</rights><rights>2023. The Author(s).</rights><rights>The Author(s) 2023. ISSN 1607-6729, Doklady Biochemistry and Biophysics, 2023, Vol. 508, pp. 12–16. © The Author(s), 2023. This article is an open access publication. ISSN 1607-6729, Doklady Biochemistry and Biophysics, 2022. © The Author(s), 2022. This article is an open access publication. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2023, ISSN 1607-6729, Doklady Biochemistry and Biophysics, 2023, Vol. 508, pp. 12–16. © The Author(s), 2023. This article is an open access publication.ISSN 1607-6729, Doklady Biochemistry and Biophysics, 2022. © The Author(s), 2022. This article is an open access publication.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c423t-359233954bfcc22105d345d3c2110f76ba1d3b32824e81797d913baaa0f7f1593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1134/S160767292270003X$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1134/S160767292270003X$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36653582$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ivanova, O. K.</creatorcontrib><creatorcontrib>Sharapova, T. N.</creatorcontrib><creatorcontrib>Romanova, E. A.</creatorcontrib><creatorcontrib>Yashin, D. V.</creatorcontrib><creatorcontrib>Sashchenko, L. P.</creatorcontrib><title>Incubation of Lymphocytes with IL-2 Causes the Appearance of Antitumor T Cells Carrying FC, CD25, and LFA-1 on the Surface</title><title>Doklady. Biochemistry and biophysics</title><addtitle>Dokl Biochem Biophys</addtitle><addtitle>Dokl Biochem Biophys</addtitle><description>To carry out antitumor activity against cells that have lost surface antigens, human lymphocytes must have a certain repertoire of surface proteins capable of contacting a tumor cell and inducing programmed cell death in it. In this work, we showed that activation of healthy donor cells by IL-2 cytokine within 6 days causes the appearance of FasL, CD25, and LFA-1 proteins on CD8+CD25+ T lymphocytes, and also converts the LFA-1 protein into an active form having a high affinity for its target, ICAM-1 integrin. The appearance of these proteins on the surface of this subpopulation of lymphocytes allows them to induce programmed cell death in HLA-negative tumor cells.</description><subject>Antigens</subject><subject>Antitumor activity</subject><subject>Apoptosis</subject><subject>Biochemistry</subject><subject>Biochemistry, Biophysics, and Molecular Biology</subject><subject>Biological and Medical Physics</subject><subject>Biomedical and Life Sciences</subject><subject>Biophysics</subject><subject>CD25 antigen</subject><subject>CD8 antigen</subject><subject>CD8-Positive T-Lymphocytes</subject><subject>Cell activation</subject><subject>Cell death</subject><subject>Cytokines</subject><subject>FasL protein</subject><subject>Humans</subject><subject>Intercellular adhesion molecule 1</subject><subject>Interleukin 2</subject><subject>Interleukin-2 - metabolism</subject><subject>LFA-1 antigen</subject><subject>Life Sciences</subject><subject>Lymphocyte Function-Associated Antigen-1 - metabolism</subject><subject>Lymphocytes T</subject><subject>Molecular Biology</subject><subject>Surface antigens</subject><subject>T-Lymphocytes - immunology</subject><subject>Tumor cells</subject><issn>1607-6729</issn><issn>1608-3091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><recordid>eNp1kU1v1DAQhiMEoqXwA7ggS1w4NOAZ58sntApdWCkShxaJm-U4zm6qjR1sp2j59XW6pXyJg2Vr3mfe8ehNkpdA3wKw7N0lFLQsSuSIJaWUfX2UnMZSlTLK4fHdu0wX_SR55v01pUiR5U-TE1YUOcsrPE1-bIyaWxkGa4jtSXMYp51Vh6A9-T6EHdk0KZJazj4Wwk6T1TRp6aRResFXJgxhHq0jV6TW-72PqHOHwWzJuj4n9QfMz4k0HWnWqxRInLF4XM6ul0o_T570cu_1i_v7LPmyvriqP6XN54-betWkKkMWUpZzZIznWdsrhQg071gWj0IA2pdFK6FjLcMKM11BycuOA2ullFHsIefsLHl_9J3mdtSd0iY4uReTG0bpDsLKQfypmGEntvZGAKUZ8mJxeHPv4Oy3WfsgxsGruK802s5eYAwBigoBI_r6L_Tazs7E_SLFocg4vTOEI6Wc9d7p_uE3QMUSrfgn2tjz6vc1Hjp-ZhkBPAI-Smar3a_R_3e9BZvoqv0</recordid><startdate>20230201</startdate><enddate>20230201</enddate><creator>Ivanova, O. K.</creator><creator>Sharapova, T. N.</creator><creator>Romanova, E. A.</creator><creator>Yashin, D. V.</creator><creator>Sashchenko, L. P.</creator><general>Pleiades Publishing</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20230201</creationdate><title>Incubation of Lymphocytes with IL-2 Causes the Appearance of Antitumor T Cells Carrying FC, CD25, and LFA-1 on the Surface</title><author>Ivanova, O. K. ; Sharapova, T. N. ; Romanova, E. A. ; Yashin, D. V. ; Sashchenko, L. P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-359233954bfcc22105d345d3c2110f76ba1d3b32824e81797d913baaa0f7f1593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antigens</topic><topic>Antitumor activity</topic><topic>Apoptosis</topic><topic>Biochemistry</topic><topic>Biochemistry, Biophysics, and Molecular Biology</topic><topic>Biological and Medical Physics</topic><topic>Biomedical and Life Sciences</topic><topic>Biophysics</topic><topic>CD25 antigen</topic><topic>CD8 antigen</topic><topic>CD8-Positive T-Lymphocytes</topic><topic>Cell activation</topic><topic>Cell death</topic><topic>Cytokines</topic><topic>FasL protein</topic><topic>Humans</topic><topic>Intercellular adhesion molecule 1</topic><topic>Interleukin 2</topic><topic>Interleukin-2 - metabolism</topic><topic>LFA-1 antigen</topic><topic>Life Sciences</topic><topic>Lymphocyte Function-Associated Antigen-1 - metabolism</topic><topic>Lymphocytes T</topic><topic>Molecular Biology</topic><topic>Surface antigens</topic><topic>T-Lymphocytes - immunology</topic><topic>Tumor cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ivanova, O. K.</creatorcontrib><creatorcontrib>Sharapova, T. N.</creatorcontrib><creatorcontrib>Romanova, E. A.</creatorcontrib><creatorcontrib>Yashin, D. V.</creatorcontrib><creatorcontrib>Sashchenko, L. P.</creatorcontrib><collection>Springer Nature OA/Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Doklady. Biochemistry and biophysics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ivanova, O. K.</au><au>Sharapova, T. N.</au><au>Romanova, E. A.</au><au>Yashin, D. V.</au><au>Sashchenko, L. P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incubation of Lymphocytes with IL-2 Causes the Appearance of Antitumor T Cells Carrying FC, CD25, and LFA-1 on the Surface</atitle><jtitle>Doklady. Biochemistry and biophysics</jtitle><stitle>Dokl Biochem Biophys</stitle><addtitle>Dokl Biochem Biophys</addtitle><date>2023-02-01</date><risdate>2023</risdate><volume>508</volume><issue>1</issue><spage>12</spage><epage>16</epage><pages>12-16</pages><issn>1607-6729</issn><eissn>1608-3091</eissn><abstract>To carry out antitumor activity against cells that have lost surface antigens, human lymphocytes must have a certain repertoire of surface proteins capable of contacting a tumor cell and inducing programmed cell death in it. In this work, we showed that activation of healthy donor cells by IL-2 cytokine within 6 days causes the appearance of FasL, CD25, and LFA-1 proteins on CD8+CD25+ T lymphocytes, and also converts the LFA-1 protein into an active form having a high affinity for its target, ICAM-1 integrin. The appearance of these proteins on the surface of this subpopulation of lymphocytes allows them to induce programmed cell death in HLA-negative tumor cells.</abstract><cop>Moscow</cop><pub>Pleiades Publishing</pub><pmid>36653582</pmid><doi>10.1134/S160767292270003X</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1607-6729
ispartof Doklady. Biochemistry and biophysics, 2023-02, Vol.508 (1), p.12-16
issn 1607-6729
1608-3091
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10042969
source MEDLINE; SpringerNature Journals
subjects Antigens
Antitumor activity
Apoptosis
Biochemistry
Biochemistry, Biophysics, and Molecular Biology
Biological and Medical Physics
Biomedical and Life Sciences
Biophysics
CD25 antigen
CD8 antigen
CD8-Positive T-Lymphocytes
Cell activation
Cell death
Cytokines
FasL protein
Humans
Intercellular adhesion molecule 1
Interleukin 2
Interleukin-2 - metabolism
LFA-1 antigen
Life Sciences
Lymphocyte Function-Associated Antigen-1 - metabolism
Lymphocytes T
Molecular Biology
Surface antigens
T-Lymphocytes - immunology
Tumor cells
title Incubation of Lymphocytes with IL-2 Causes the Appearance of Antitumor T Cells Carrying FC, CD25, and LFA-1 on the Surface
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T18%3A40%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incubation%20of%20Lymphocytes%20with%20IL-2%20Causes%20the%20Appearance%20of%20Antitumor%20T%20Cells%20Carrying%20FC,%20CD25,%20and%20LFA-1%20on%20the%20Surface&rft.jtitle=Doklady.%20Biochemistry%20and%20biophysics&rft.au=Ivanova,%20O.%20K.&rft.date=2023-02-01&rft.volume=508&rft.issue=1&rft.spage=12&rft.epage=16&rft.pages=12-16&rft.issn=1607-6729&rft.eissn=1608-3091&rft_id=info:doi/10.1134/S160767292270003X&rft_dat=%3Cproquest_pubme%3E2791649069%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2791649069&rft_id=info:pmid/36653582&rfr_iscdi=true